5 Biggest Medical Device Companies in the World

Page 1 of 5

In this article we will take a look at the 5 biggest medical device companies in the world. If you want to know more about the industry and discover additional companies, take a look at 15 Biggest Medical Device Companies in the World.

5. Edwards Lifesciences Corporation (NYSE:EW)

Market Cap as of November 18: $45.58 B
Number of Hedge Fund Holders: 57

Edwards Lifesciences Corporation (NYSE:EW) places a high premium on patient-centered medical advancements for heart disease and critical care monitoring. The company’s products are divided into three categories: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care.

On October 28, Cowen analyst Joshua Jennings maintained an ‘Outperform’ rating and trimmed his price objective on Edwards Lifesciences Corporation (NYSE:EW) to $100 from $125. According to the analyst, ongoing issues with the company’s employees, a spike in COVID in Japan, and a higher yen caused the company’s TAVR for the third quarter to fall short of forecasts.

At the end of Q3, Fisher Asset Management was the leading shareholder of Edwards Lifesciences Corporation (NYSE:EW), holding over 7.54 million shares. Overall, 57 hedge funds in Insider Monkey’s database were bullish on Edwards Lifesciences Corporation (NYSE:EW) in Q3, up from 39 in the previous quarter.

Here is what Wedgewood Partners said about Edwards Lifesciences Corporation (NYSE:EW) in its Q3 2022 investor letter:

“Edwards Lifesciences Corporation (NYSE:EW) reported just +5% growth in revenue (foreign exchange adjusted) compared to a year ago. While this quarter represented a deceleration in revenue growth from earlier this year, much of that was due to hospital staffing shortages and the vagaries of global healthcare systems emerging from pandemic disruptions. The Company received FDA approval for its minimally invasive mitral valve repair system, PASCAL, and also presented compelling related clinical data, which should help support accelerating growth over the next few years. As for Edwards’ core TAVR system, there continues to be a (unfortunately) pent-up, untreated population suffering from severe aortic stenosis that will finally be able to find their way back into healthcare systems as labor market pressures ease.”

Follow Edwards Lifesciences Corp (NYSE:EW)


Page 1 of 5